1,445 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Tomtom NV 2018 Q2 - Results - Earnings Call Slides https://seekingalpha.com/article/4187766-tomtom-nv-2018-q2-results-earnings-call-slides?source=feed_all_articles Jul 17, 2018 - The following slide deck was published by Tomtom NV in conjunction with their 2018 Q2 earnings call.
Novartis AG (NVS) CEO Vasant Narasimhan on Q2 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4188067-novartis-ag-nvs-ceo-vasant-narasimhan-q2-2018-results-earnings-call-transcript?source=feed_sector_healthcare Jul 18, 2018 - Novartis AG (NYSE:NVS) Q2 2018 Results Earnings Conference Call July 18, 2018, 08:00 AM ET Executives Samir Shah - Global Head of IR Vasant Narasimhan - CEO Shannon Klinger - Legal Counsel Liz Barrett
Tomtom NV 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4211840-tomtom-nv-2018-q3-results-earnings-call-slides?source=feed_all_articles Oct 16, 2018 - The following slide deck was published by Tomtom NV in conjunction with their 2018 Q3 earnings call.
Materialise NV 2018 Q3 - Results - Earnings Call Slides https://seekingalpha.com/article/4216383-materialise-nv-2018-q3-results-earnings-call-slides?source=feed_all_articles Oct 31, 2018 -
3 Drug Stocks to Report Earnings on Jul 19: JNJ, NVS, NEOG http://www.zacks.com/stock/news/223699/3-drug-stocks-to-report-earnings-on-jul-19-jnj-nvs-neog?cid=CS-ZC-FT-223699 Jul 18, 2016 - Three drug stocks including industry bellwether Johnson & Johnson (JNJ) will report results on Jul 19.
Novartis (NVS) Likely to Beat Q2 Earnings: Stock to Gain? http://www.zacks.com/stock/news/223654/novartis-nvs-likely-to-beat-q2-earnings-stock-to-gain?cid=CS-ZC-FT-223654 Jul 15, 2016 - Novartis AG (NVS) is scheduled to report second-quarter 2016 results on Jul 19.
AEGON NV: It's Closing Time For This Preferred Stock https://seekingalpha.com/article/4058629-aegon-nv-closing-time-preferred-stock?source=feed_sector_financial Mar 28, 2017 - AEB has reached levels where the upside potential is limited by its fundamentals.Floating Rate preferred stocks have had a good year so far, but at some point it is wise to cash in.There are other opt
Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around? https://www.fool.com/investing/2017/04/25/will-low-pricing-for-siliq-be-enough-to-help-valea.aspx?source=iedfolrf0000001 Apr 25, 2017 - Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
Nyrstar NV (NYRSF) Presents At BofAML 2017 Global Metals, Mining and Steel Conference https://seekingalpha.com/article/4075284-nyrstar-nv-nyrsf-presents-bofaml-2017-global-metals-mining-steel-conference?source=feed_sector_financial May 22, 2017 - The following slide deck was published by Nyrstar NV in conjunction with this event.
Mylan NV (MYL) Q1 2017 Results - Earnings Call Transcript https://seekingalpha.com/article/4071852-mylan-nv-myl-q1-2017-results-earnings-call-transcript?source=feed_sector_healthcare May 10, 2017 - Mylan NV (NASDAQ:MYL)Q1 2017 Earnings CallMay 10, 2017 10:00 am ETExecutivesMelissa Trombetta - Mylan NVHeather M. Bresch - Mylan NVRajiv Malik - Mylan NVAnthony Mauro - Mylan NVKenneth Scott Parks -

Pages: 123456789...145

<<<Page 4>